Fusion Antibodies PLC (LSE:FAB)
£ 0.10 -0.0025 (-2.33%) Market Cap: 13.14 Mil Enterprise Value: 13.28 Mil PE Ratio: 0 PB Ratio: 17.50 GF Score: 26/100

Fusion Antibodies PLC Investor Presentation and Q&A Session Transcript

Dec 16, 2025 / 04:00PM GMT
Release Date Price: £0.1625 (-7.14%)
Adrian Kinkaid
Fusion Antibodies PLC - Chief Executive Officer, Executive Director

Hello. My name is Adrian Kinkaid. I'm the CEO of Fusion Antibodies, and I'm in San Diego today to help with the launch of OptiMAL at the Antibody Engineering and Therapeutics show. So what I wanted to do was update our investors with the latest happenings, and so we thought we would try this webinar format.

So the presentation I'm going to give is just a short extract from Rick's presentation on the main conference. And I'll just talk you through some of the highlights. I won't be able to do the full scientific justice that Rick can do; we simply don't have the time. However, if there are questions that are arising, then there is a facility on the Investor Hub to ask those towards the end.

So for anybody who doesn't know,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot